期刊文献+

ABCG8 T400K基因多态性与高脂血症的关系 被引量:2

Interactions between ATP binding cassette G8 T400K polymorphisms and hyperlipidemia.
原文传递
导出
摘要 目的探讨ABCG8 T400K基因多态性与高血脂症的相关性。方法采用酚-氯仿法提取370例高脂血症患者及303例健康志愿者DNA,用聚合酶链反应-限制性片断长度多态性(PCR-RFLP)技术检测ABCG8 T400K基因多态性,用χ2检验检测基因多态性与高脂血症的关系。结果ABCG8 T400K基因多态性与高脂血症患病风险间显著相关,ABCG8 400K等位基因为患高脂血症的高风险因素(OR=1.870,P=0.002)。结论ABCG8 T400K基因多态性与高脂血症患病风险间显著相关,ABCG8 400K等位基因携带者患高脂血症的风险较高。 Objective To investigate the effects of ABCG8 T400K gene polymorphisms on hyperlipidemia. Methods DNA of 303 healthy controls and the 370 hyperlipidemic subjects was extracted from peripheral blood with the method of phenol - chloroform. ABCG8 T400K polymorphism was screened by polymerase chain reaction - restriction fragment length polymovphism(PCR - RFLP). Chi -square test was used to analyzed interactions between ABCG8 T400K polymorphism and hyperlipidemia. Results There was great relationship between the polymorphism of ABCG8 T400K and hyperlipidemia, and the allele of ABCG8 400K predicted the hyperlipidemic events(OR=1.870, P = 0.002). Conclusion There was great relationship between the polymorphism of ABCG8 T400K and hyperlipidemia, there was higher risks in the subjects with allele of ABCG8 400K.
出处 《河南预防医学杂志》 2009年第4期246-247,254,共3页 Henan Journal of Preventive Medicine
基金 郑州市科技攻关计划项目(074SGY33195-16)
关键词 ABCG8 T400K 基因多态性 高血脂症 ABCG8 T400K genetic polymorphism hyperlipidemia
  • 相关文献

参考文献9

  • 1Hubacek JA, Berge KE, Stefkova J, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels[J]. Physiol Res. 2004, 53(4): 395 -401.
  • 2MIWA K, INAZU A, KOBAYASHI J, et al. ATP- binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects [ J ]. Clin Sci ( Lond ) , 2005,109 (2) : 183 - 188.
  • 3韦侃侃,贾敏,付强,高远,杨万雷,张莉蓉.影响他汀类药物降脂治疗的相关基因的多态性及其与高脂血症的关系[J].中国新药与临床杂志,2008,27(8):570-575. 被引量:13
  • 4Turley SD, Dietschy JM. Sterol absorption by the small intestine[J]. Curr Opin Lipidol. 2003,14 (3) : 233 -240.
  • 5Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters[J]. Science. 2000,290(5497): 1771 -1775.
  • 6Hubacek JA, Berge KE, Cohen JC, et al. Mutations in ATP -cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia [J]. Hum Mutat. 2001, 18(4): 359 -360.
  • 7Heimerl S, Langmann T, Moehle C, et al. Mutations in the human ATP - binding cassette transporters ABCG5 and ABCG8 in sitosterolemia [ J ]. Hum Mutat. 2002,20(2) : 151.
  • 8Wittenburg H, Carey MC. Biliary cholesterol secretion by the twinned sterol half - transporters ABCG5 and ABCG8 [ J ]. J Clin Invest. 2002,110 5) : 605 - 609.
  • 9王勇,吴卫泽,韩天权,蒋兆彦,费健,姜志宏,秦俭,蔡杏兴,张圣道.ABCG8基因T400K多态性与胆囊结石病以及血脂水平的关系[J].外科理论与实践,2006,11(6):510-513. 被引量:3

二级参考文献36

  • 1蒋兆彦,韩天权,所广军,袁作彪,姜志宏,商俊,蔡杏兴,Gsta Eggertsen,Curt Einarsson,张圣道.胆固醇结石病人肝脏胆小管侧膜ATP基因表达差异的研究[J].外科理论与实践,2005,10(1):61-65. 被引量:24
  • 2胡永芳,周宏灏.CYP3A4,CYP3A5和MDR1基因多态性对环孢素处置的影响[J].中国药理学通报,2005,21(3):257-261. 被引量:34
  • 3秦俭,韩天权,费健,蒋兆彦,张宇,杨士勇,姜志宏,蔡杏兴,黄薇,张圣道.家族性胆囊结石病发病因素研究[J].中华医学杂志,2005,85(28):1966-1969. 被引量:11
  • 4van SCHAIK RH, van der HEIDEN IP, van den ANKER JN, et al. CYP3A5 variant allele frequencies in Dutch Caucasians [J]. Clin Chem, 2002, 48(10) : 1668-1671.
  • 5HOFFMEYER S, BURK O, von RICHTER O, et al. Functional polymorphism of the human multidrug-resistance gene : multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J]. Proc Natl Acad Sci USA, 2000, 97(7) : 3473-3478.
  • 6TIRONA RG, LEAKE BF, MERINO G, et al. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European-and African- Americans[J]. J Biol Chem, 2001, 276(38): 35669-35675.
  • 7LEE E, RYAN S, BIRMINGHAM B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment [J]. Clin Pharmacol Ther, 2005, 78(4): 330-341.
  • 8COUTURE P, OTVOS JD, CUPPLES LA, et al. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study[J]. J Lipid Res, 1999, 40(10) : 1883-1889.
  • 9MIWA K, INAZU A, KOBAYASHI J, et al. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects[J]. Clin Sci(Lond), 2005, 109(2): 183-188.
  • 10KUEHL P, ZHANG J, LIN Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression[J]. Nat Genet, 2001, 27(4): 383-391.

共引文献14

同被引文献33

  • 1沈振斌,秦新裕,童赛雄,锁涛.ABCG5和ABCG8在肝细胞胆固醇转运中的作用[J].中华肝胆外科杂志,2005,11(10):695-697. 被引量:3
  • 2王勇,韩天权,张圣道.ABCG5和ABCG8与胆固醇代谢关系的研究进展[J].国际外科学杂志,2006,33(2):125-128. 被引量:11
  • 3Junyent M, Tucker KL, Smith CE, et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study[J]. J Lipid Res, 2009,50(3):565.
  • 4Koeijvoets KC, van der Net JB, Dallinga-Thie GM, et al. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia[J]. Atherosclerosis, 2009,204(2) :453.
  • 5Becker ML, Visser LE, van Schaik RH, et al. Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males [J]. Pharmacogenotnies ,2009, 10( 11 ) :1 743.
  • 6Keskitalo JE, Pasanen MK, Neuvonen PJ, et al. Different effects of the ABCG2 c.421C > A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin [ J ]. Pharmacogenomics,2009,10(10) :1 617.
  • 7Hubaek JA, Berge KE, Stefkova J, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels[J]. Physiol Res,2004,53(4):395.
  • 8Hokanson J E,Austin M A.Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level:a meta-analy-sis of population-based prospective studies[J].J Card-iovasc Risk,1996,3:213-219.
  • 9Macisz A,Kisfali P,Horvatovich K,Mohds M,Marko L,Csongei V,et al.Apolipoprotein A5 T-1131 C variant confers risk for metabolic syndrome[J].Pathol Oncol Res,2007,13:243-247.
  • 10Zhang Z,Tao L,Chen Z,Zhou D,Kan M,Zhang D,et al.Association of genetic loci with blood lipids in the Chinese population[J].PLoS One,2011,6:e27305.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部